Follow-up report on pulmonary mucosa-Associated lymphoma in a patient with von Hippel-Lindau disease

Bukola A. Olarewaju, Judy B. Tejon, Mayowa A. Osundiji (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

9 Downloads (Pure)

Abstract

With the increasing opportunities for medical management of von Hippel-Lindau (VHL)-related lesions, fundamental questions are arising regarding the possibilities of the FDA-Approved medication (Belzutifan) to delay the progression of other non-VHL-related tumors that are not requiring urgent surgical interventions. We present a follow-up report on a VHL patient, with a co-morbid history of pulmonary mucosa-Associated lymphoid tissue lymphoma, who was initially described in the clinical scientific literature ~10 years ago. This patient's case highlights some of the challenges for some VHL patients with comorbid non-VHL-related tumors and potential opportunities for targeted support.

Original languageEnglish
Article numberrjae619
Number of pages2
JournalJournal of Surgical Case Reports
Volume2024
Issue number10
DOIs
Publication statusPublished - 5 Oct 2024

Keywords

  • lymphoma
  • tumor
  • von Hippel-Lindau

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Follow-up report on pulmonary mucosa-Associated lymphoma in a patient with von Hippel-Lindau disease'. Together they form a unique fingerprint.

Cite this